Suggestive Evidence for an Antidepressant Effect of Metreleptin Treatment in Patients with Lipodystrophy

INTRODUCTION: Lipodystrophy (LD) syndromes are rare heterogeneous disorders characterized by reduction or absence of subcutaneous fat, low or nondetectable leptin concentrations in blood and impaired hunger/satiety regulation. Metreleptin treatment reverses metabolic complications and improves eatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Vieira, Diana Branco, Antel, Jochen, Peters, Triinu, Miehle, Konstanze, Stumvoll, Michael, Hebebrand, Johannes, Schlögl, Haiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669995/
https://www.ncbi.nlm.nih.gov/pubmed/36037795
http://dx.doi.org/10.1159/000526357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669995/
https://www.ncbi.nlm.nih.gov/pubmed/36037795
http://dx.doi.org/10.1159/000526357

Ejemplares similares